INmune Bio, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 939,468 | $5.06 M | 100.00% | 4.65% |
| PRAETORIAN PR LLC | 11/14/2024 | 780,800 | $4.21 M | 60.99% | 3.87% |
| VANGUARD GROUP INC | 11/13/2024 | 720,712 | $3.88 M | 14.71% | 3.57% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 10/18/2024 | 369,438 | $1.99 M | 62.37% | 1.83% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 344,466 | $1.86 M | 6.58% | 1.71% |
| STATE STREET CORP | 11/14/2024 | 226,428 | $1.22 M | 35.11% | 1.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 213,400 | $1.15 M | 215.68% | 1.06% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 202,504 | $1.09 M | 118.52% | 1.00% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 178,284 | $960,951 | 0.00% | 0.88% |
| MAI CAPITAL MANAGEMENT | 11/07/2024 | 160,758 | $866,486 | 0.11% | 0.80% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 107,200 | $577,808 | 100.00% | 0.53% |
| MORGAN STANLEY | 11/14/2024 | 92,144 | $496,656 | 224.74% | 0.46% |
| MARSHALL WACE, LLP | 11/14/2024 | 79,888 | $430,596 | -31.08% | 0.40% |
| CORTON CAPITAL INC. | 11/14/2024 | 76,143 | $410,411 | 270.62% | 0.38% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 11/20/2024 | 71,315 | $384,397 | 57.29% | 0.35% |
| ROYAL BANK OF CANADA | 11/14/2024 | 62,086 | $334,000 | -0.82% | 0.31% |
| HEIGHTS CAPITAL MANAGEMENT, INC | 11/14/2024 | 60,978 | $328,671 | 100.00% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 49,552 | $267,084 | -15.44% | 0.25% |
| CITADEL ADVISORS LLC | 11/14/2024 | 46,400 | $250,096 | 1,833.33% | 0.23% |
| XTX TOPCO LTD | 11/14/2024 | 46,253 | $249,304 | 100.00% | 0.23% |
| CITADEL ADVISORS LLC | 11/14/2024 | 46,116 | $248,565 | 50.26% | 0.23% |
| UBS GROUP AG | 11/14/2024 | 43,156 | $232,611 | 7.11% | 0.21% |
| FERMATA ADVISORS, LLC | 10/09/2024 | 42,730 | $230,315 | 25.16% | 0.21% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 33,990 | $183,206 | -8.81% | 0.17% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 33,701 | $181,648 | 100.00% | 0.17% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 33,009 | $177,919 | 183.17% | 0.16% |
| LAIRD NORTON TRUST COMPANY, LLC | 11/14/2024 | 32,850 | $177,062 | 4.29% | 0.16% |
| DIAMETRIC CAPITAL, LP | 11/13/2024 | 29,455 | $158,762 | 100.00% | 0.15% |
| CITADEL ADVISORS LLC | 11/14/2024 | 29,300 | $157,927 | 136.29% | 0.15% |
| BARCLAYS PLC | 11/19/2024 | 29,044 | $157,000 | 601.89% | 0.14% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 26,434 | $142,479 | 124.66% | 0.13% |
| 11/25/2024 | 21,045 | $102,489 | 100.00% | 0.10% | |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 16,518 | $89,032 | 0.00% | 0.08% |
| JANE STREET GROUP, LLC | 11/15/2024 | 14,725 | $79,367 | 100.00% | 0.07% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 14,648 | $78,953 | 100.00% | 0.07% |
| LPL FINANCIAL LLC | 11/08/2024 | 14,342 | $77,303 | 7.05% | 0.07% |
| RHUMBLINE ADVISERS | 11/12/2024 | 14,320 | $77,177 | 3.97% | 0.07% |
| FINANCIAL ADVOCATES INVESTMENT MANAGEMENT | 10/25/2024 | 13,500 | $72,765 | 17.39% | 0.07% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 11/14/2024 | 13,482 | $72,668 | 100.00% | 0.07% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 12,184 | $65,672 | 100.00% | 0.06% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 10,727 | $57,819 | 100.00% | 0.05% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 7,233 | $38,986 | 10.14% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 6,809 | $36,701 | 100.00% | 0.03% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 6,700 | $36,113 | -17.92% | 0.03% |
| JPMORGAN CHASE & CO | 11/08/2024 | 5,874 | $31,661 | 12.92% | 0.03% |
| NEWEDGE ADVISORS, LLC | 11/14/2024 | 5,000 | $26,950 | -52.27% | 0.02% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 4,222 | $22,756 | 6.54% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 3,082 | $16,612 | 100.00% | 0.02% |
| FMR LLC | 11/13/2024 | 1,424 | $7,675 | 1,575.29% | 0.01% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 1,358 | $7,319 | 0.00% | 0.01% |
INmune Bio, Inc.institutional Ownership - FAQ's
During the previous two years, 74 institutional investors and hedge funds held shares of INmune Bio, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 939,468
Praetorian PR LLC: 780,800
VANGUARD GROUP INC: 720,712
Raymond James Financial Services Advisors, Inc.: 369,438
GEODE CAPITAL MANAGEMENT, LLC: 344,466
STATE STREET CORP: 226,428
26.51% of INmune Bio, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6.67 M shares in the last 24 months. This purchase volume represents approximately $29.93 M in transactions.